morning welcome scientific fourth quarter conference call name coordinate call today operator instruction would like introduce moderator call vice president investor relation begin call vice president investor relation good morning thank join call today chairman president chief executive officer senior vice president chief financial officer please note call webcast live archive investor section website thermofisher head news event copy press release fourth quarter earn available investor section website head financials begin briefly cover safe harbor statement various remark make company future expectation plan prospect constitute premium statement purpose safe harbor provision private security security litigation reform actual result differ materially indicate forward look statement result various important factor include discuss company recent annual report form subsequent quarterly report form file available investor section website head financials file elect update forward look statement point future specifically disclaim obligation even estimate change therefore rely forward look statement represent view subsequent today also call refer certain financial measure prepare accordance generally accept account principle reconciliation financial measure directly comparable measure available press release fourth quarter full year earn also investor section website head financials turn call chairman president chief executive officer thank good morning everyone thank join today fourth quarter call wrap truly exceptional year scientific deliver another quarter strong result reflect year three thing stand prove growth strategy power business system continue drive outstanding financial performance customer demand strong core business perform gain market share continue play lead role societal response finally continue build trust partner status customer give great confidence bright future continue create sustainable value stakeholder detail remark later first recap financials start quarter revenue billion adjust operate income billion adjust operate margin adjust share turn result full year grow revenue billion adjust operate income increase billion expand adjust operate margin basis point deliver increase adjust share build tremendous success incredibly proud stellar performance really testament strength global prove growth strategy result another year exceptional financial result share gain give color result quarter year start pharma biotech outstanding performance deliver growth fourth quarter full year addition strong market dynamic result drive unique customer value proposition lead role support customer across wide range excite therapeutic area include role support vaccine therapy year broad base strength across business market include bioproduction pharma service bioscience chromatography mass spectrometry business research safety market channel academic government decline single digit quarter strong demand year period grow double digit full year year good growth across range business particularly bioscience electron microscopy research safety market channel turn industrial apply grow teen quarter grow high teen full year year strong growth electron microscopy chromatography mass spectrometry business research safety market channel finally diagnostics healthcare revenue lower prior year quarter revenue grow high single digit full year throughout year execute really support customer test need base business strong growth immunodiagnostics transplant diagnostic business move growth strategy provide comment role pandemic response quarter generate billion response relate revenue drive emergence omicron variant lead strong test demand significant role enable vaccine therapy production throughout continue operate speed scale meet customer need relate generate total response revenue billion billion vaccine therapy proud role continue play around world enable customer government fight pandemic time execute core business strategy incredibly provide update progress make execute prove growth strategy consist three element know develop high impact innovative product leverage scale high growth emerge market deliver unique value proposition customer make outstanding progress share highlight start first pillar fantastic year high impact innovation launch number product across business strengthen industry leadership enable customer advance important work bioproduction business launch high performer single available size liter latest advancement single technology bring benefit single technology unprecedented volume performance ensure consistent scalability pilot scale study commercial production chromatography mass spectrometry continue innovate across life science research biopharmaceutical development year extend impact industry lead platform bring high resolution analysis range application include toxicology metabolomics fourth quarter launch scientific mass detector provide high throughput analysis improve development production electron microscopy introduce scientific wafer dual beam scan electron microscope support development increasingly smaller complex semiconductor genetic science apply real time system launch enable clinical test laboratory accelerate molecular diagnostics second pillar growth strategy leverage scale high growth emerge market create differentiate experience customer continue strengthen capability serve market highlight example increase capacity single technology open manufacture site serve local global demand biopharma customer south continue enhance local capability customer focus innovation center semiconductor industry biopharma customer additional capability position really support customer need third pillar growth strategy unique customer value proposition continue significantly accelerate organic investment capability capacity even better partner customer invest billion capital meet short long term customer demand highlight include expansion sterile fill finish network bioproduction enzyme plasmid product capacity always business system mission drive culture major factor success year enable rapid execution capital investment help find better every continue bring innovative solution customer work efficiently effectively operate speed scale create even greater value stakeholder turn capital deployment active year strengthen customer value proposition continue successfully execute discipline capital deployment strategy combination strategic return capital shareholder active invest billion complete transaction strengthen customer value proposition highlight addition close super excite colleague part company share expertise work together enhance innovation productivity pharma biotech customer perform high level business deliver great result enter outstanding momentum significantly ahead original expectation time deal announcement customer feedback extremely positive excite pipeline opportunity build execute prove integration methodology element business system create value stakeholder position deliver year three synergy million million operate income revenue synergy track deliver million synergy year complete acquisition lead provider recombinant protein excellent complement industry lead bioscience business also return billion capital shareholder stock buyback dividend turn brief update progress priority proud past year significantly advance environmental social governance initiative mission enable customer make world healthier cleaner safer never relevant highlight year include commitment achieve carbon neutrality build earlier goal reduce greenhouse emission across operation enhance report transparency expand corporate social responsibility report alignment multiple report framework actively engage community foundation science student globally stem education program goal make positive impact community live work like review guidance high level take detail significantly raise revenue earn guidance increase result strong performance core business increase assumption test relate revenue raise full year revenue guidance billion billion would result revenue growth increase adjust guidance share summarize takeaway execute continue growth momentum deliver outstanding financial performance business perform gain market share exceptional performance momentum enter enable raise outlook incredibly position future prove growth strategy position deliver long term core organic revenue growth hand call senior vice president chief financial officer thank good morning everyone press release deliver excellent quarter another outstanding year full year deliver organic growth include organic base business growth billion response revenue deliver growth adjust earn share billion free cash flow significantly invest company enable really bright future proud accomplish year result significantly ahead prior guidance walk element beat deliver billion revenue include prior guide include billion higher response revenue million revenue acquisition million higher base business revenue last earn call risk test response revenue guidance additional opportunity support customer test need ready follow benefit exactly term base business deliver base business organic growth point higher assume prior guide good performance particularly give four fewer sell quarter excellent momentum line core business great growth trajectory continue step meet customer test need business system enable generate great pull strong revenue performance lead excellent adjust performance deliver adjust quarter full year ahead prior guide broad base beat round outstanding year provide detail performance begin earn result mention deliver adjust quarter full year adjust compare last year quarter full year versus prior year line report revenue grow year year component revenue increase include organic revenue decrease contribution acquisition headwind foreign exchange mention base business organic revenue growth quarter full year report revenue increase include organic growth contribution acquisition tailwind foreign exchange full year base business organic growth deliver billion response revenue include billion vaccine therapy support revenue turn performance geography organic growth rate region skew response revenue current prior year four fewer sell versus prior year quarter north decline teen grow high single digit pacific grow high single digit rest world grow single digit full year north grow double digit grow pacific grow include growth rest world grow teen tend operational performance adjust operate income decrease adjust operate margin basis point lower last year full year adjust operate income increase adjust operate margin basis point higher quarter business system enable deliver strong volume leverage base business strong productivity offset impact lower test response revenue ongoing strategic investment across business support near long term growth full year drive positive volume leverage productivity also favorable business partially offset strategic investment move detail total company adjust gross margin quarter come basis point lower last year full year adjust gross margin basis point versus prior year fourth quarter full year change gross margin driver adjust operate margin adjust revenue full year adjust revenue improvement basis point compare total expense approximately million full year expense billion represent growth prior year reflect ongoing investment high impact innovation fuel future growth look result line quarter interest expense million million higher last year largely finance activity interest expense full year million increase million adjust income expense income quarter million million higher mainly change operate full year adjust income expense income million million lower prior year adjust rate quarter basis point lower last year mainly different level profitability year year full year adjust rate basis point higher average dilute share million approximately million lower year year drive share repurchase option dilution full year average share million turn cash flow balance sheet cash flow another great highlight year cash flow operate activity billion prior year free cash flow year billion invest billion capital expenditure reflect strong return generate short term investment make long term year return approximately billion capital shareholder stock buyback dividend billion cash total debt billion billion sequentially largely result finance activity relate acquisition leverage ratio quarter time gross debt adjust time debt basis conclude comment total company performance adjust basis point last year continue generate exceptional return provide color performance four business segment start frame comment scale margin profile response revenue vary segment consistent throughout year continue make strategic investment across business size investment necessarily align response revenue segment skew segment margin four fewer sell year quarter finally recently laboratory product segment reflect inclusion acquisition laboratory product biopharma service segment also forward refer clinical research business within segment move segment detail start life science solution report revenue segment decrease organic revenue lower prior year quarter quarter deliver strong growth bioproduction bioscience business offset lower revenue genetic science business drive lower test revenue versus year quarter full year report revenue segment increase organic revenue increase adjust operate income life science solution decrease adjust operate margin basis point year year quarter deliver strong productivity offset unfavorable business strategic investment full year adjust operate income increase adjust operate margin decrease basis point versus analytical instrument segment report revenue increase organic growth growth segment quarter drive electron microscopy chromatography mass spectrometry business full year report revenue segment increase organic revenue increase adjust operate income segment increase adjust operate margin basis point year year quarter favorable business deliver strong volume pull productivity enable business system partially offset strategic investment make across segment full year adjust operate income increase adjust operate margin increase basis point versus turn specialty diagnostics report revenue organic revenue lower year quarter quarter strong growth transplant diagnostics immunodiagnostics business offset lower test revenue versus year quarter full year report revenue segment increase organic revenue increase adjust operate income decrease quarter adjust operate margin basis point prior year drive positive productivity enable business system offset unfavorable volume strategic investment segment full year adjust operate income decrease adjust operate margin decrease basis point versus finally laboratory product biopharma service segment report revenue segment increase organic revenue growth strong growth pharma service laboratory product business recognize million revenue clinical research business full year report revenue segment increase organic revenue increase adjust operate income segment increase adjust operate margin basis point higher prior year quarter drive strong productivity business system favorable business partially offset strategic investment full year adjust operate income increase adjust operate margin increase basis point versus turn update guidance detail like begin quick reminder definition core business introduce investor last year note transition core include base business vaccine therapy response revenue acquisition give scale acquisition core organic growth calculation include full year basis think give best view look total company business perform full transparency also continue provide total company organic growth report actual performance move guidance mention significantly increase full year revenue adjust outlook raise full year revenue guidance billion billion raise adjust guidance strong raise reflect excellent strength business continue expect core organic revenue growth provide additional detail update guidance start revenue whether four element drive billion raise billion increase test assumption million increase core business million decrease change rate million increase reflect acquisition close year term test revenue assumption continue risk approach guidance range outcome year guidance assume billion test revenue scenario test demand could higher level case position support customer need follow benefit think prudent continue take risk approach outlook term core revenue raise million relate reflect excellent strength business lesser extent recent change around defer revenue measurement acquisition expect clinical research business deliver billion revenue full year represent organic growth full year basis growth deliver remain million core revenue raise reflect strong finish rest core business core business great shape even scale mention earlier continue expect grow organically strong raise overall revenue guidance business system generate strong pull revenue expect adjust operate margin basis point higher assume prior guidance term adjust stronger business outlook enable raise adjust guidance build already strong outlook year provide couple detail help model mention expect deliver billion revenue billion adjust operate income acquisition expect contribute adjust year expect deliver revenue million adjust expect year year headwind million revenue adjust continue assume adjust income rate expect full year interest approximately million income million continue assume capital expenditure approximately billion free cash flow approximately billion guidance still assume billion capital deployment billion share buyback already complete million capital return shareholder dividend estimate full year average dilute share count million million share finally couple comment phase help model term revenue dollar assumption guide revenue dollar fairly linear year slightly higher risk assumption test guidance assume revenue front load first half year assume pandemic rate level million revenue quarter second half year organic growth core business expect fairly consistent throughout year term adjust phase guidance assume slightly weight toward first half year phase last year percentage full year conclude deliver another outstanding year great position achieve goal turn call back vice president investor relation thank operator ready take question